A detailed history of Godsey & Gibb Associates transactions in Johnson & Johnson stock. As of the latest transaction made, Godsey & Gibb Associates holds 2,190 shares of JNJ stock, worth $340,326. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,190
Previous 3,503 37.48%
Holding current value
$340,326
Previous $511,000 30.72%
% of portfolio
0.03%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$145.48 - $167.38 $191,015 - $219,769
-1,313 Reduced 37.48%
2,190 $354,000
Q2 2024

Jul 23, 2024

BUY
$144.38 - $157.78 $161,416 - $176,398
1,118 Added 46.88%
3,503 $511,000
Q1 2024

Apr 23, 2024

SELL
$155.22 - $162.74 $182,073 - $190,894
-1,173 Reduced 32.97%
2,385 $377,000
Q4 2023

Jan 16, 2024

BUY
$145.6 - $158.88 $154,627 - $168,730
1,062 Added 42.55%
3,558 $557,000
Q3 2023

Oct 25, 2023

SELL
$155.75 - $174.48 $10,746 - $12,039
-69 Reduced 2.69%
2,496 $388,000
Q2 2023

Jul 25, 2023

SELL
$154.35 - $166.11 $118,386 - $127,406
-767 Reduced 23.02%
2,565 $424,000
Q1 2023

Apr 18, 2023

SELL
$151.05 - $180.26 $48,336 - $57,683
-320 Reduced 8.76%
3,332 $516,000
Q4 2022

Jan 18, 2023

BUY
$160.2 - $179.79 $585,050 - $656,593
3,652 New
3,652 $0
Q2 2022

Jul 25, 2022

SELL
$168.19 - $186.01 $562,427 - $622,017
-3,344 Closed
0 $0
Q1 2022

Apr 28, 2022

SELL
$158.14 - $179.59 $97,097 - $110,268
-614 Reduced 15.51%
3,344 $593,000
Q4 2021

Feb 15, 2022

BUY
$155.93 - $173.01 $617,170 - $684,773
3,958 New
3,958 $677,000
Q2 2021

Aug 05, 2021

SELL
$159.48 - $171.07 $998,504 - $1.07 Million
-6,261 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$153.07 - $170.48 $958,371 - $1.07 Million
6,261 New
6,261 $1.03 Million
Q1 2021

May 13, 2021

SELL
$153.07 - $170.48 $991,128 - $1.1 Million
-6,475 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$137.11 - $157.38 $146,022 - $167,609
1,065 Added 19.69%
6,475 $1.02 Million
Q3 2020

Nov 10, 2020

BUY
$140.38 - $153.83 $8,422 - $9,229
60 Added 1.12%
5,410 $805,000
Q2 2020

Aug 12, 2020

SELL
$128.81 - $155.51 $4,637 - $5,598
-36 Reduced 0.67%
5,350 $752,000
Q1 2020

May 11, 2020

BUY
$111.14 - $153.99 $103,471 - $143,364
931 Added 20.9%
5,386 $706,000
Q4 2019

Feb 06, 2020

SELL
$127.5 - $146.44 $92,692 - $106,461
-727 Reduced 14.03%
4,455 $650,000
Q3 2019

Nov 13, 2019

SELL
$126.95 - $142.14 $118,190 - $132,332
-931 Reduced 15.23%
5,182 $670,000
Q2 2019

Aug 07, 2019

SELL
$131.15 - $144.24 $157,773 - $173,520
-1,203 Reduced 16.44%
6,113 $851,000
Q1 2019

May 14, 2019

BUY
$125.72 - $139.79 $96,301 - $107,079
766 Added 11.69%
7,316 $1.02 Million
Q4 2018

Feb 13, 2019

SELL
$122.84 - $147.84 $563,098 - $677,698
-4,584 Reduced 41.17%
6,550 $845,000
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $38,905 - $45,721
320 Added 2.96%
11,134 $1.54 Million
Q2 2018

Aug 14, 2018

SELL
$119.4 - $131.76 $36,417 - $40,186
-305 Reduced 2.74%
10,814 $1.31 Million
Q1 2018

May 11, 2018

SELL
$125.1 - $148.14 $12.1 Million - $14.3 Million
-96,567 Reduced 89.67%
11,119 $1.43 Million
Q4 2017

Jan 23, 2018

SELL
$131.22 - $143.62 $520,287 - $569,453
-3,965 Reduced 3.55%
107,686 $15 Million
Q3 2017

Nov 03, 2017

SELL
$129.47 - $135.38 $1.61 Million - $1.68 Million
-12,398 Reduced 9.99%
111,651 $14.5 Million
Q2 2017

Aug 11, 2017

BUY
N/A
124,049
124,049 $16.4 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Godsey & Gibb Associates Portfolio

Follow Godsey & Gibb Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Godsey & Gibb Associates, based on Form 13F filings with the SEC.

News

Stay updated on Godsey & Gibb Associates with notifications on news.